Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Egg harvesting for stem cell research

Women’s health and human rights advocates worldwide are increasingly concerned that overzealous pursuit of new scientific discoveries may once again be threatening women’s health. This time, young women are being asked to donate or sell their ova, not only for use in fertility clinics, but increasingly for non-clinical use in experimental cloning research.

Diane Beeson and Abby Lippman, based at California State University and McGill University, Montreal respectively, report on medical risks and ethical problems associated with collection of human oocytes (eggs) during IVF practice from donors who give them to other women who desperately want a child. Doubts are emerging about donating oocytes in this manner, even when recipients use them to establish a pregnancy. Their article Egg harvesting for stem cell research: medical risks and ethical problems is published in the journal Reproductive BioMedicine Online [ – e-pub ahead of print 14 August 2006].

Widely practised in IVF, but not yet proven to be fully safe, various hormones are given to donors to stimulate several eggs to develop. Using ultrasound, ripe oocytes are then aspirated from within their follicles. The oocytes are often donated free, although the HFEA has given permission for donors to receive some compensation via discounts for their own IVF treatment. In one case reported, the donor oocytes were needed for stem cell research, which makes ethicists even more furious about ‘selling’ human oocytes.

It is hard to separate ethically this decision from giving direct payments to donors, or from fertilizing the eggs and then giving them away for research. In all these examples, many donors might have suffered from mild symptoms of ovarian hyperstimulation, among other disorders, without their knowledge.

Recent research has stressed the risks of using hormonal stimulants to induce follicle growth and ovulation in women. Surprisingly, Beeson and Lippman claim that pharmaceutical companies have not been compelled to submit their information on the risks of such forms of ovulation induction to the US Food and Drug Administration. Claims are made of 25 deaths among donors, although this requires verification. Claims that cancers may be induced in some patients have been questioned or denied, although an increase arose in another study on >3500 women donors, and critics stress that many of these studies had short-term follow-ups in only a few women. These patients were among the first to attempt IVF, and their risks of tumours are now emerging and will be analysed in the near future.

IVF children have not yet displayed such anomalies, though significant abnormalities are reported in offspring of mice following similar treatments. These investigating authors nevertheless cited earlier reports on anomalies, including cancers, in offspring of women receiving exogenous hormones, perhaps due to the release of steroids. In view of all these known and unknown risks to women donors, these authors refer to organizations established to protect women undergoing IVF and other ovarian treatments. It is one thing, however, to raise a fuss about uncertain risks but quite another to gain hard data from the complex reports emerging in the world of assisted human conception.

Fiona Bennett | alfa
Further information:

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>